UPDATE 2-Biogen scraps Alzheimer drug trials, shares slump by a quarter

* Failure comes after Eisai CEO expressed confidence (Adds background, analyst comment; updates share price)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.